Maintenance dose : Take 1 scoop in the morning before breakfast
Ozempic (semaglutide) activates GLP-1 receptors to suppress appetite and regulate blood sugar, while Zepbound (tirzepatide) activates both GIP and GLP-1 receptors, delivering stronger satiety signals and greater average weight loss
If semaglutide doesn't agree with you, there are alternatives to discuss that's a conversation, not a dead end
Not because they don't eat well, but because the amount their body needs has quietly increased at exactly the point when most of us aren't thinking about it
ALT has been demonstrated to decline in patients with treatmentrelated improvement or resolution of histological NASH in studies of obeticholic acid,45 elafibranor46 and liraglutide,23 and also shown to decline in association with liver fat reductions among patients with type 2 diabetes and NAFLD treated with the sodiumglucose cotransporter 2inhibitor empagliflozin.47 While correlated outcomes do not always indicate a causative association, several studies have also observed a predictive association between changes in ALT and subsequent NAFLD/NASHrelated outcomes
